AFP and neoplasm: Increased values of alpha-fetoprotein can predict tumor recurrence following resection, the level of response to loco-regional therapy, the drop-out risk among patients awaiting liver transplantation (LT), as well as survival and tumor recurrence following LT, and survival in advanced HCC.